Welkin Health Inc.

Welkin Health Inc. provides innovative care management software that enhances patient engagement and optimizes operational efficiencies for healthcare providers. Its platform supports healthcare organizations in managing patient care from diagnosis through treatment. Welkin Health Inc.

, founded in 2013 and headquartered in San Francisco, US, specializes in care management solutions for the healthcare sector. The company has completed four deals, with its most recent funding round being a Series B in May 2019, raising USD 17. 50 mn from Altos Ventures, along with Asset Management Ventures, Red Swan Ventures, and Thrive Capital. The current CEO is Michelle Pampin, although no previous founding history was noted.

Welkin Health offers a comprehensive care management software platform that streamlines patient care and operational workflows for healthcare providers. Its core product facilitates patient interaction management throughout the care journey, featuring real-time record updates, automated intake processes, and multi-channel communication tools. The platform is designed for various sectors, including substance use programs and orthopedic care, ultimately aiming to improve patient outcomes and reduce unnecessary surgeries. Welkin's clientele consists of diverse healthcare organizations across the US, including community health centers and hospitals.

Welkin Health generates revenue through a subscription-based model tailored to the needs of healthcare providers. Clients enter agreements allowing access to the platform, which includes patient record management and advanced analytics. The pricing structure accommodates organizations of all sizes, ensuring effective utilization by both small clinics and large health systems. The business model focuses on direct B2B transactions with healthcare providers.

In May 2019, Welkin Health Inc. raised USD 17. 50 mn in Series B funding led by Altos Ventures, which will be utilized to further develop the company's software offerings and expand its market reach. Plans are underway to launch new features that enhance patient engagement, with specific focus on entering additional healthcare markets and geographic regions.

The company targets expansion efforts through 2023 to ensure a broader impact on healthcare delivery across the United States.